LucyDx

LucyDx

Closed: Apr. 2025

About this raise

LucyDx, with a valuation of $8 million, is raising funds on NetCapital. It is a medical technology company developing a diagnostic headset for the early detection of diabetic retinopathy. The non-invasive and compact headset of LucyDx is based on an electroretinogram and aims to prevent blindness through early detection. LucyDx has pinpointed its target market, validated demand, and is working with researchers at Emory University, Georgia Tech, and the VA Atlanta Medical Center. Andreas Inmann and Antoin Johnson founded LucyDx in February 2021. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1 million. The campaign proceeds will be used for product development, regulatory affairs, operations and payroll, prototyping, and testing.

Expand

Investment Overview

Invested this round: $12,192

Deal Terms

Total Commitments

Platform
Netcapital
Start Date
03/30/2023
Close Date
04/30/2025
Min. Goal
$10,000
Max Goal
$608,000
Min. Investment

$104

Security Type

Equity - Common

Company Stage

Early Stage

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$8.00

Pre-Money Valuation

$8,000,000

Company & Team

Company

Year Founded
2021
Industry
Healthcare & Pharmaceuticals
Tech Sector
Medtech
Distribution Model
B2B2C
Margin
Medium
Capital Intensity
High
Location
NEWARK, Delaware
Business Type
Growth
Company Website
Visit Website

Team

Employees
2
Prior Founder Exits?
No
Founder Name
Andreas Inmann
Title
President & COO
Founder Name
Antoin Johnson
Title
CTO

Financials

 Revenue
$0
as of FY2023
 Monthly Burn
$1,323
as of FY2023
 Runway
6.8 months
as of FY2023

Summary Profit and Loss Statement

FY 2023 FY 2022

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-15,878

$1,035

Summary Balance Sheet

FY 2023 FY 2022

Cash

$9,031

$14,362

Accounts Receivable

$0

$0

Total Assets

$9,031

$14,362

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Total Prior Capital Raised
$4,000
VC Backed?
No
Close Date Platform Valuation Total Raised Security Type Status Reg Type
04/30/2025 Netcapital $8,000,000 $12,192 Equity - Common Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
LucyDx on NetCapital 2023
Platform: Netcapital
Security Type: Equity - Common
Valuation: $8,000,000
Price per Share: $8.00

Follow company

Follow LucyDx on NetCapital 2023

Buy LucyDx's Deal Report

Warning: according to the close date for this deal, LucyDx may no longer be accepting investments.

LucyDx Deal Report

Get Kingscrowd's comprehensive report on LucyDx including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether LucyDx is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the LucyDx deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge